Probability of cancer in pulmonary nodules detected on first screening CT.

BACKGROUND Major issues in the implementation of screening for lung cancer by means of low-dose computed tomography (CT) are the definition of a positive result and the management of lung nodules detected on the scans. We conducted a population-based prospective study to determine factors predicting the probability that lung nodules detected on the first screening low-dose CT scans are malignant or will be found to be malignant on follow-up. METHODS We analyzed data from two cohorts of participants undergoing low-dose CT screening. The development data set included participants in the Pan-Canadian Early Detection of Lung Cancer Study (PanCan). The validation data set included participants involved in chemoprevention trials at the British Columbia Cancer Agency (BCCA), sponsored by the U.S. National Cancer Institute. The final outcomes of all nodules of any size that were detected on baseline low-dose CT scans were tracked. Parsimonious and fuller multivariable logistic-regression models were prepared to estimate the probability of lung cancer. RESULTS In the PanCan data set, 1871 persons had 7008 nodules, of which 102 were malignant, and in the BCCA data set, 1090 persons had 5021 nodules, of which 42 were malignant. Among persons with nodules, the rates of cancer in the two data sets were 5.5% and 3.7%, respectively. Predictors of cancer in the model included older age, female sex, family history of lung cancer, emphysema, larger nodule size, location of the nodule in the upper lobe, part-solid nodule type, lower nodule count, and spiculation. Our final parsimonious and full models showed excellent discrimination and calibration, with areas under the receiver-operating-characteristic curve of more than 0.90, even for nodules that were 10 mm or smaller in the validation set. CONCLUSIONS Predictive tools based on patient and nodule characteristics can be used to accurately estimate the probability that lung nodules detected on baseline screening low-dose CT scans are malignant. (Funded by the Terry Fox Research Institute and others; ClinicalTrials.gov number, NCT00751660.).

[1]  G. Sanders,et al.  Validation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodules , 2007, Thorax.

[2]  Patrick Royston,et al.  Multivariable Model-Building: A Pragmatic Approach to Regression Analysis based on Fractional Polynomials for Modelling Continuous Variables , 2008 .

[3]  D. Berry,et al.  Benefits and harms of CT screening for lung cancer: a systematic review. , 2012, JAMA.

[4]  Sunil J Rao,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2003 .

[5]  H. D. de Koning,et al.  Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial. , 2013, American journal of respiratory and critical care medicine.

[6]  H. D. de Koning,et al.  NELSON lung cancer screening study , 2011, Cancer imaging : the official publication of the International Cancer Imaging Society.

[7]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[8]  Timothy R Church,et al.  Selection criteria for lung-cancer screening. , 2013, The New England journal of medicine.

[9]  M. Gould,et al.  A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules. , 2007, Chest.

[10]  S. Lam,et al.  Lung cancer screening: a different paradigm. , 2003, American journal of respiratory and critical care medicine.

[11]  E. Glatstein,et al.  CT Screening for Lung Cancer: Five-Year Prospective Experience , 2006 .

[12]  M. L. R. D. Christenson,et al.  Guidelines for Management of Small Pulmonary Nodules Detected on CT Scans: A Statement From the Fleischner Society , 2006 .

[13]  S. Lam,et al.  Lung Cancer Screening Using Multi-Slice Thin-Section Computed Tomography and Autofluorescence Bronchoscopy , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[14]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[15]  B. Kramer,et al.  Cumulative Incidence of False-Positive Test Results in Lung Cancer Screening , 2010, Annals of Internal Medicine.

[16]  B. van Ginneken,et al.  Pulmonary perifissural nodules on CT scans: rapid growth is not a predictor of malignancy. , 2012, Radiology.

[17]  M Terrin,et al.  Reference spirometric values using techniques and equipment that meet ATS recommendations. , 2015, The American review of respiratory disease.

[18]  S. Bölükbas,et al.  Management of lung nodules detected by volume CT scanning. , 2010, The New England journal of medicine.

[19]  M. L. R. D. Christenson.  Perifissural Nodules Seen at CT Screening for Lung Cancer , 2011 .

[20]  Michael K Gould,et al.  Decision making in patients with pulmonary nodules. , 2012, American journal of respiratory and critical care medicine.

[21]  S. Lam,et al.  Lung nodules: CT-guided placement of microcoils to direct video-assisted thoracoscopic surgical resection. , 2009, Radiology.

[22]  M. L. R. D. Christenson,et al.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2012 .

[23]  P. Prorok,et al.  Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation. , 2011, Journal of the National Cancer Institute.

[24]  Gary Longton,et al.  Estimation and Comparison of Receiver Operating Characteristic Curves , 2009, The Stata journal.

[25]  L. Tanoue.  CT Screening for Lung Cancer: Five-year Prospective Experience , 2007 .

[26]  M. Roizen.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[27]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[28]  S. Swensen,et al.  The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. , 1997, Archives of internal medicine.

[29]  Matthew B Schabath,et al.  Lung cancer screening. , 2003, Journal of the National Comprehensive Cancer Network : JNCCN.

[30]  Ella A. Kazerooni,et al.  Lung cancer screening: Clinical practice guidelines in oncology , 2012 .

[31]  H. White.  A Heteroskedasticity-Consistent Covariance Matrix Estimator and a Direct Test for Heteroskedasticity , 1980 .

[32]  J. Cuzick,et al.  A Wilcoxon-type test for trend. , 1985, Statistics in medicine.